$NEU large move, base, need to form RS (tighten) ready for B/O$NEU large move, base, need to form RS (tighten) ready for B/O
Next report date
Report period
H1 2024
EPS estimate
0.13USD
Revenue estimate
24.09 MUSD
0.84USD
106.94 MUSD
157.89 MUSD
110.12 M
About NEUREN PHARMACEUTICALS LIMITED
Sector
CEO
Jonathan Charles Pilcher
Headquarters
Camberwell
Website
Founded
2004
ISIN
NZNEUE0001S8
FIGI
BBG000QP8YL9
Neuren Pharmaceuticals Ltd. is a biopharmaceutical company, which engages in the development of new therapies for brain injury, neurodevelopment, and neurodegenerative disorders. Its products include Pipeline, Trofinetide, and NNZ-2591. The company was founded on December 17, 2001 and is headquartered in Camberwell, Australia.
Neuren Had A Classical Minervini / Upper Bollinger Breakout RunAnother great mover on todays Australian Stock Exchange.
Classic Bollinger breakout after a long sideways squeeze and volume coming through as well.
NEU 6 month breakout 1.48 and good buying up this week. $NEU Neuren Pharmaceutical with good buying this week. Not much news out, but investor presentation this week. 6 month breakout $1.48. Strong support 1.25 Some director buying around 1.40. MC $170m SOI 115m. $neu.ax
NEU waiting game, Patience, patience ...NEU holding support at 2.89 very nicely, a lot of accumulation, a matter of time before this one start running
NEU Great fundamental/all indicators in the greenNEU double bottomed after double toped, show consolidation, Downtrend breakout and MACD turning green showing sign of moving opposite direction.
1st Price target of 3.50 short Term ( 14% ) , if break through 6.45 could become the next target .
$NEU trendline break post recent consolidationFirst consolidation post consolidation. moving through trendline, see if it can re-test old highs.
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of NURPF is 12.51 USD — it hasn't changed in the past 24 hours. Watch Neuren Pharmaceuticals Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Neuren Pharmaceuticals Ltd. stocks are traded under the ticker NURPF.
Neuren Pharmaceuticals Ltd. is going to release the next earnings report on Aug 27, 2024. Keep track of upcoming events with our Earnings Calendar.
NURPF stock is 0% volatile and has beta coefficient of 1.68. Track Neuren Pharmaceuticals Ltd. stock price on the chart and check out the list of the most volatile stocks — is Neuren Pharmaceuticals Ltd. there?
NURPF earnings for the last quarter are 0.25 USD per share, whereas the estimation was 0.21 USD resulting in a 14.95% surprise. The estimated earnings for the next quarter are 0.67 USD per share. See more details about Neuren Pharmaceuticals Ltd. earnings.
Neuren Pharmaceuticals Ltd. revenue for the last quarter amounts to 42.89 M USD despite the estimated figure of 41.62 M USD. In the next quarter revenue is expected to reach 112.53 M USD.
Yes, you can track Neuren Pharmaceuticals Ltd. financials in yearly and quarterly reports right on TradingView.
NURPF stock has fallen by 1.18% compared to the previous week, the month change is a 6.99% fall, over the last year Neuren Pharmaceuticals Ltd. has showed a 32.66% increase.
NURPF net income for the last quarter is 74.39 M USD, while the quarter before that showed 31.84 M USD of net income which accounts for 133.66% change. Track more Neuren Pharmaceuticals Ltd. financial stats to get the full picture.
Today Neuren Pharmaceuticals Ltd. has the market capitalization of 1.59 B, it has decreased by 0.12% over the last week.
No, NURPF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, NURPF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Neuren Pharmaceuticals Ltd. stock right from TradingView charts — choose your broker and connect to your account.
NURPF reached its all-time high on Dec 28, 2023 with the price of 17.20 USD, and its all-time low was 0.0004 USD and was reached on May 18, 2016. View more price dynamics on NURPF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Neuren Pharmaceuticals Ltd. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Neuren Pharmaceuticals Ltd. stock shows the buy signal. See more of Neuren Pharmaceuticals Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Neuren Pharmaceuticals Ltd. future price: according to them, NURPF price has a max estimate of 20.11 USD and a min estimate of 14.79 USD. Watch NURPF chart and read a more detailed Neuren Pharmaceuticals Ltd. stock forecast: see what analysts think of Neuren Pharmaceuticals Ltd. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Neuren Pharmaceuticals Ltd. EBITDA is 135.64 M USD, and current EBITDA margin is 85.91%. See more stats in Neuren Pharmaceuticals Ltd. financial statements.